Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.

Autor: Fernandez K; Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA., Hoetink A; Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.; Audiology, Utrecht Medical Center Utrecht Brain Center, Utrecht, the Netherlands.; Audiology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Audiology, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Konrad-Martin D; National Center for Rehabilitative Auditory Research, Veterans Affairs Rehabilitation Research and Development, Veterans Affairs Portland Health Care System, Portland, Oregon, USA.; Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA., Berndtson D; International Ototoxicity Management Group, Cancer Survivor and Advocate, Vienna, Virginia, USA., Clark K; National Center for Rehabilitative Auditory Research, Veterans Affairs Rehabilitation Research and Development, Veterans Affairs Portland Health Care System, Portland, Oregon, USA.; Department of Otolaryngology/Head & Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.; Veterans Affairs Health Services Research & Development Center of Innovation, Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D 66), Portland, Oregon, USA.; Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA., Dreisbach L; School of Speech, Language, and Hearing Sciences, San Diego State University, San Diego, California, USA., Geller JI; Division of Audiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Goffi-Gomez MV; Division of Audiology, AC Camargo Cancer Center, São Paulo, Brazil., Grosnik A; Division of Audiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Jamis C; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA., Knight K; Department of Audiology, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon, USA., Lee DS; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Lee J; Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA., Liberman PHP; Division of Audiology, AC Camargo Cancer Center, São Paulo, Brazil., Milnes T; Department of Audiology, Veterans Affairs Augusta Health Care System, Augusta, Georgia, USA., Meijer AJM; Audiology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Audiology, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Ortiz CE; Capital Institute of Hearing & Balance, Silver Spring, Maryland, USA., Rooker J; College of Nursing, University of South Florida, Tampa, Florida, USA., Sanchez VA; Department of Otolaryngology-Head & Neck Surgery, University of South Florida, Tampa, Florida, USA., van den Heuvel-Eibrink MM; Audiology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Audiology, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Brewer CC; Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA., Poling GL; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Ear and hearing [Ear Hear] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients.

Autor: Zeng, Juanzi^1,2 (AUTHOR), Wu, Heming^2,3 (AUTHOR), Liu, Donghua^1,2 (AUTHOR), Li, Liang^1,2 (AUTHOR), Li, Jiaquan^1,2 (AUTHOR), Wang, Qiuming^1,2 (AUTHOR), Ye, Min^1,2 (AUTHOR), Huang, Qingyan^2,3 (AUTHOR), Yu, Zhikang^2,3 (AUTHOR), Zhang, Jinfeng^1,2 (AUTHOR) sciyilushunfeng80@163.com

Publikováno v: World Journal of Surgical Oncology. 6/22/2022, Vol. 20 Issue 1, p1-9. 9p.

Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.

Autor: Paken, Jessica¹ (AUTHOR) pakenj@ukzn.ac.za, Govender, Cyril D.¹ (AUTHOR), Pillay, Mershen¹ (AUTHOR), Ayele, Birhanu T.² (AUTHOR), Sewram, Vikash² (AUTHOR) vsewram@sun.ac.za

Publikováno v: BMC Cancer. 7/16/2021, Vol. 21 Issue 1, p1-11. 11p.

Systematic Review and Meta‐Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum‐Based Chemotherapy.

Autor: Hong, Daniel Z., Ong, Thaned C. C., Timbadia, Dhayan P., Tan, Hui T. A., Kwa, Eunice D., Chong, Wan Q., Goh, Boon C., Loh, Woei S., Loh, Kwok S., Tan, Ene C., Tay, Joshua K.

Publikováno v: Otolaryngology-Head & Neck Surgery; Jun2023, Vol. 168 Issue 6, p1324-1337, 14p